BU BÖLÜM HAKKINDA
Addiction treatment has historically relied on self-reporting and intermittent check-ins. Rachel Hobert, CEO of Huml Health, joins the show to discuss how her company is using wearable technology and voice biomarkers to provide clinicians with a clearer, continuous picture of a patient's health. We discuss the role of data in predicting struggles, the importance of the mind-body connection, and the challenges of innovating within a slow-to-adopt healthcare industry.
Key Takeaways
- The Shift to Passive Monitoring: Addiction treatment is moving from relying solely on patient self-reports to using objective biometric data like heart rate variability and sleep patterns to understand how a patient is truly doing.
- A Tool for Clinicians: Huml Health acts as a clinical decision support tool rather than a diagnostic device, surfacing engagement signals that help doctors ask the right questions at the right time.
- Connection is Key: The opposite of addiction is connection. Technology can facilitate that connection by keeping families and clinicians informed and engaged throughout the recovery journey.
- Overcoming Industry Hurdles: Healthcare innovation faces significant barriers, including slow adoption and misaligned incentives. Success requires a clear purpose and persistence.
Resources Mentioned
Huml Health
Canary Speech
Dr. Scott Lucas (Harvard McLean Medical School)
If you found this episode helpful, please subscribe to the show on your favorite platform and share it with someone who might benefit from this conversation. Your support helps us bring more of these vital stories to light.
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.
Technical Podcast Support by Jon Keur at Wayfare Recording Co.
